Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irinotecan Hydrochloride Liposome Injection

Approval Number

国药准字H20234150

Company石药集团欧意药业有限公司

Registration Date

September 12, 2023

Drug Information

Generic Name

盐酸伊立替康脂质体注射液

Dosage Form

注射剂

Strength

10ml：43mg（按C₃₃H₃₈N₄O₆计）

Drug Type

化学药品

Registration Date

September 12, 2023

Company Information

Applicant Company

Company Name石药集团欧意药业有限公司

Company Address

石家庄经济技术开发区扬子路88号

Manufacturing Company

Company Name石药集团欧意药业有限公司

Company Address

石家庄经济技术开发区扬子路88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy